Broadview Ventures is a mission-driven fund dedicated to improving human health, particularly in cardiovascular disease and stroke. They invest in early-stage companies to advance health technologies reaching patients. Supporting both startups and established biotech firms, Broadview Ventures aims to make a significant impact in medical science and patient care. Companies like Acesion Pharma and IsomAb have benefited from their funding, driving advancements in the field. Their success is measured by the ability of these technologies to improve lives.
